Pure Global

Impact of supplementation with folic acid on blood pressure in patient with essential hypertension - Trial PACTR202011602578460

Access comprehensive clinical trial information for PACTR202011602578460 through Pure Global AI's free database. This Not Applicable trial is sponsored by University of Gezira and is currently Not yet recruiting. The study focuses on Cardiology.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR202011602578460
Not Applicable
Not yet recruiting
drug
Trial Details
Pan Africa Clinical Trials Registry โ€ข PACTR202011602578460
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Impact of supplementation with folic acid on blood pressure in patient with essential hypertension

Study Focus

Cardiology

drug

Sponsor & Location

University of Gezira

Mustafa Saleh Saeed

Sudan

Timeline & Enrollment

Not Applicable

Jun 16, 2020

Dec 30, 2020

Summary

Hypertension is a common global health problem in many countries including Sudan. In the year 2000, more than 25% of the world's population was estimated to have hypertension. This percentage is expected to increase to around 30% by the year 2025. In 2010, the global prevalence of hypertension among adults aged โ‰ฅ 20 years was estimated to be 31.1%. In addition to that, the proportion of worldwide morbid complications due to hypertension has significantly increased from approximately 4.5 % in 2000 to 7 % in 2010 which makes hypertension the most important cause of morbidity and mortality globally. In Sudan, the prevalence of hypertension was increased from > 20% in the year 2000 to 35 - < 40 % in the year 2010. In the urban communities of Sudan, the prevalence of hypertension has increased from 7.5% in 1990 to 18.2% in 2002. The Seventh Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) has defined hypertension was as a systolic BP >140 mm Hg, a diastolic BP > 90 mm Hg. This study aims to evaluate the impact of folic acid plus antihypertensive medications compared with antihypertensive medications alone on lowering blood pressure in patients with primary hypertension.

ICD-10 Classifications

Cardiomyopathy
Cardiomegaly
Cardiac catheterization
Cardiomyopathy, unspecified
Injury of heart

Data Source

Pan Africa Clinical Trials Registry

PACTR202011602578460

Non-Device Trial